In addition to its role in shaping the tumor immune microenvironment—particularly by promoting CD8+ T-cell and dendritic cell infiltration—BCL9 has also been shown to influence endothelial cell fate in a mouse model of colon cancer. Here, BCL9 is linked to malignant colon neoplasm.